Introduction
Telomere shortening limits the proliferative capacity of primary human cells to a finite number of cell divisions (Harley et al., 1990; Allsopp et al., 1992) . A variety of tissues and organs show telomere shortening during human aging (Djojosubroto et al., 2003) and accelerated telomere shortening has been detected in chronic diseases with elevated rates of cell turnover (Djojosubroto et al., 2003) . These studies have fueled speculations that telomere shortening might limit the regenerative capacity of organs during aging and chronic diseases. In agreement with this hypothesis hepatocellular telomere shortening has been linked to the cirrhosis stage (Wiemann et al., 2002) , which is characterized by a decline in hepatocyte proliferation and activation of senescence pathways (Briscioli et al., 1995; Delhaye et al., 1996 Delhaye et al., , 1999 Albrecht et al., 1997) . Studies in telomerase deficient mice (mTERC À/À ) have given experimental evidence that telomere shortening affects organ homeostasis (Lee et al., 1998) and regenerative capacity during aging (Blasco et al., 1997; Herrera et al., 1999; Rudolph et al., 1999) . It has been shown that critical telomere shortening at cellular level inhibits cells from entering the cell cycle, thus limiting the population of proliferating cells within an organ system (Satyanarayana et al., 2003) . In addition to impaired cell cycle entry, telomere shortening affected cell cycle progression at the G2/M-stage and increased the rate of apoptosis in response to high regenerative pressure .
Telomerase gene delivery was sufficient to rescue regenerative defects induced by telomere shortening in mTERC À/À mice . Another target for the treatment of regenerative exhaustion induced by telomere shortening could be the inhibition of senescence signaling. The clinical use of telomerase activators or senescence inhibitors will ultimately depend on its effect on cancer formation. In most human tissues telomerase expression is suppressed after birth -a process thought to be a tumor suppressor mechanism to inhibit the growth of eventually transformed cells at the senescence stage (Wright et al., 1996) . In line with this hypothesis over 80% of human malignant tumors show reactivation of telomerase (Satyanarayana et al., 2004) and many genes of the senescence pathway are mutated in human cancer, for example, p53, p21 (Stewart and Weinberg, 2000) . In contrast, human cancers including HCC are characterized by the presence of critical short telomeres compared to longer telomeres in noncancerous surrounding tissue (Plentz et al., 2003 (Plentz et al., , 2004 . Studies in mTERC À/À mice have revealed an explanation for this apparent paradox showing that telomere shortening has a dual role in cancer formation (Rudolph et al., 1999; Artandi et al., 2000) . On the one hand, telomere shortening and telomere dysfunction induces chromosomal instability (CIS) and tumor initiation Wong et al., 2000) . On the other hand, telomere dysfunction inhibits tumor progression by activating senescence responses resulting in cell cycle arrest and apoptosis (Greenberg et al., 1999; GonzalezSuarez et al., 2000; Rudolph et al., 2001; Ramirez et al., 2003) . Together, these data suggest that telomere shortening limits regenerative responses during aging and chronic organ damage and that it represents a risk factor for the development of cancer but at the same time inhibits tumor progression. To target telomeres for future therapies in regenerative medicine, it will be crucial to understand which of these diverse effects of telomere shortening is dominantly affecting survival.
In the current study we analysed the effects of telomere shortening in mTERC À/À mice carrying the Hepatitis-B-virus-surface-antigen (HBsAg) under the liver specific albumin-promotor (Chisari et al., 1987) . HBsAg-trangenic mice (HbsAg þ ) exhibit chronic liver damage resulting in HCC-formation in 12-15 months old animals (Chisari et al., 1989) . Our study shows that telomere shortening reduced the survival of mice in the setting of chronic liver damage despite reducing the risk of HCC development. These data give experimental support that targeting telomeres could be beneficial for overall survival in specific clinical settings.
Results
Telomere shortening reduces survival in HBsAg þ mice
The survival of HBsAg þ and HBsAg À control mice was followed in mTERC þ / þ and different generations of mTERC À/À mice ( Figure 1 ). It is important to note that in accordance with previous studies (Herrera et al., 1999) , telomere shortening in G3mTERC À/À mice did not have a significant impact on survival of HBsAg À mice in the C57/B6-mouse strain that was used in our studies ( Figure 1a ). In contrast, G3mTERC
À/À HBsAg þ mice showed a significant reduced lifespan compared to G3mTERC Figure 1b) . Together, these data indicated that only a combination of both -telomere shortening in G3mTERC À/À mice and chronic liver damage in HBsAg þ mice -affected the survival of the mice. In accordance with the previously described higher level of chronic liver damage in male compared to female HBsAg þ mice (Chisari et al., 1989) , there was a tendency of a shorter lifespan in male G3mTERC À/À HBsAg þ mice compared to female mice G3mTERC À/À HBsAg þ mice (Figure 1c ).
Telomere shortening induces liver cell aneuploidy but reduces liver tumor progression in HBsAg þ mice
It was described that HBsAg þ mice develop early preneoplastic liver lesions at an age of 5-10 months, which progress towards HCC in male mice at an age of 12-15 months (Chisari et al., 1989) . Previous studies have revealed a dual role of telomere shortening on tumor initiation and progression Greenberg et al., 1999; Rudolph et al., 1999; Artandi et al., 2000; Rudolph et al., 2001 ) including hepatocarcinogenesis (Farazi et al., 2003) . In our current study we analysed ploidy of liver cells by Feulgen staining, the incidence of premalignant liver lesions (hepatic foci and adenoma) and the rate of HCC in HBsAg þ and HBsAg À mTERC þ / þ and G3mTERC À/À mice. In accordance with the hypothesis that telomere shortening initiates tumors by induction of CIS, the rate of liver cell aneuploidy was significantly increased in G3mTERC (Figure 2a ). HBsAg À mice did not show a significant rate of liver cell aneuploidy, suggesting that telomere short- were first observed in 10 months old HBsAg þ mice. Premalignant liver changes were detected in all mice of both cohorts. There was a tendency of a reduced number of damage foci in G3mTERC À/À compared to mTERC þ / þ mice, indicating that in this model of chronic liver damage telomere shortening inhibited tumor formation already at the level of premalignant lesions (data not shown). At the age of 15 months, 88.9% (8/9) of male mTERC þ / þ HBsAg þ mice developed nodules on the liver surface compared to only 33.4% (3/9) of male G3mTERC À/À HBsAg þ mice (Po0.05, Figure 2b ). At this age the histological analysis revealed that 44.5% of male mTERC þ / þ HBsAg þ mice developed HCC compared to complete absence of HCC in male G3mTERC À/À HBsAg þ mice ( Figure 2b ). Together these data were in line with previous studies showing that telomere shortening inhibits the progression of liver tumors (Farazi et al., 2003) .
Telomere shortening impairs liver homeostasis, growth of HbsAg negative areas and induces liver cell hypertrophy in HBsAg þ mice
The apparent paradox of reduced survival despite suppressed tumor formation in G3mTERC (Figure 3a , P>0.05). At the same time point the rate of TUNEL-positive apoptotic liver cells was significantly elevated in G3mTERC (Figure 3b , Po0.05). Together, there was a severe imbalance between the number of proliferating liver cells and the number of apoptotic cells in G3mTERC (Figure 3c , Po0.05). In HBsAg À mice there was no significant rate of PCNA-labeling or apoptosis in both mTERC þ / þ and G3mTERC À/À mice (data not shown). Previous studies have shown that during continuous liver damage in the HBsAg þ mouse model regenerative nodules appear showing a silencing of HBsAg-gene expression (Chisari et al., 1989) . In our cohort of HBsAg þ mice the regenerative HBsAg À areas appeared in 5 months old mice and showed constant growth with age and an association with proliferating liver cells (Figure 3d and e). In accordance with the imbalance between proliferating liver cells and liver cell apoptosis, we detected a significant retardation in the growth of HBsAg (Figure 4c and d) . Together, these data indicated that short telomeres in the setting of chronic liver damage affected the balance between apoptotic liver cells and regenerating liver cells thus resulting in impaired growth of regenerative areas, which was compensated by liver cell hyperplasia.
Gene expression changes induced by telomere shortening and chronic liver damage affect mitosis regulating genes To understand molecular mechanisms related to altered liver homeostasis induced by chronic liver damage and telomere shortening we conducted a high-density oligonucleotide microarray experiment. Our above results had revealed a delayed growth of HBsAg-negative regenerative areas in mTERC À/À mice compared to mTERC þ / þ mice (see above) resulting in a decreased fraction of HBsAg À liver cells in G3mTERC À/À mice compared to mTERC þ / þ mice (Figure 3b and e). To exclude that differences in the size of the population of HBsAg þ liver cells had an effect on changes in liver gene expression, we used the mouse model of chronic liver damage induced by repeated injections of carbon tetrachloride (CCl 4 ) (Edwards and Dalton, 1942; Eschenbrenner and Miller, 1946) . In this experiment we collected liver tissue from late generation of mTERC À/À mice and mTERC þ / þ control mice after 2 weeks of chronic CCl 4 -injections (three injections per week). In addition, we explored whether telomerase reactivation by mTERC-gene delivery could rescue eventual gene expression changes induced by telomere shortening in the setting of chronic 
À/À HBsAg À mice, and (d) G3mTERC À/À HBsAg þ mice liver damage. For this purpose mice were infected with a mTERC-expressing adenovirus (AdmTERC) or a control adenovirus (AdGFP) and gene expression changes were analysed in a total of three cohorts of mice: (1) mTERC
mTERC À/À AdGFP and (3) mTERC À/À AdmTERC . Our analysis revealed 30 genes that were differentially expressed in mTERC À/À AdGFP compared to mTERC þ / þ AdGFP mice (Table 1) . Interestingly, this list contained four genes that have a known function in mitosis progression. The differential expression of two of these mitosis-regulating genes was confirmed by quantitative RT-PCR ( Figure 5 ). mTERC-gene delivery partially rescued gene expression changes induced by telomere shortening (Table 1) . For example, the expression changes of cdc20, ayk-1 (Aurora-A in humans) and PRC-1 (Protein regulator of cytokinesis) were rescued after mTERC gene delivery, whereas the gene expression change of MCM10 (activator of DNA-prereplication complex) was only partially rescued.
Discussion
Our study gives experimental evidence that in the setting of chronic liver damage the negative impact of telomere shortening on organ homeostasis and organismal Gene expression changes were analysed in an oligonucleotide microarray experiment. Column 1 shows the fold change in gene expression during chronic liver damage comparing liver tissues from mTERC +/+ AdGFP mice (basis) with liver tissue from mTERC À/À AdGFP mice with shortened telomeres. Column 2 shows the fold change in gene expression during chronic liver damage comparing mTERC +/+ AdGFP mice (basis) with mTERC À/À AdmTERC mice after adenovirus-mediated reactivation of telomerase. Note that some of the differentially expressed genes in mTERC À/À mice were normalized/partially normalized by telomerase gene delivery ('n' or 'p', column 5) survival is dominant over the positive effect of telomere shortening regarding tumor suppression. For our studies we have chosen late generations of mTERC À/À mice (G3 in C57/B6 background), which have not yet exhibited decreased survival due to telomere shortening by itself in the absence of additional organ damage (Herrera et al., 1999 ) but yet possessed shortened telomeres and signs of telomere dysfunction as seen in senescent human cells and aged human tissues (23). Our study shows that this level of telomere shortening in combination with chronic liver damage results in decreased mouse survival. Interestingly, in this experimental setting telomere shortening reduces survival despite a strong inhibition of tumor development in these mice: The formation of macroscopic liver nodules was reduced and HCC were completely absent in the G3mTERC À/À HBsAg þ mice compared to mTERC þ / þ HBsAg þ mice. In contrast to these data on inhibition of tumor progression, the rate of aneuploidy and CIS -a mechanism of tumor initiation -was significantly increased in G3mTERC À/À HBsAg þ mice compared to mTERC þ / þ HBsAg þ mice. These data are in agreement with previous observation of increased tumor initiation by induction of CIS in mTERC À/À mice (Rudolph et al., 2001; Farazi et al., 2003) . However, in our study we detected the suppression of premalignant lesions in G3mTERC
A possible explanation could be that HBsAg-induced cytotoxicity in combination with telomere shortening and CIS would result in apoptosis even before formation of microscopic lesions. Our study suggests that impaired organ homeostasis during chronic liver damage in mTERC À/À mice is due to an imbalance between the rate of apoptotic liver cells and proliferating liver cells. This imbalance results in a delayed growth of regenerative HBsAg À areas of hepatocytes, which have silenced the expression of the hepatotoxic HBsAgtransgene (Chisari et al., 1989) . These data are in accordance with previous studies showing that the growth of regenerative nodules is impaired by telomere shortening in the uPA-transgene-mouse-model of acute liver failure . Our data indicate that liver cell hypertrophy in G3mTERC À/À mice compared to mTERC þ / þ mice compensated the imbalance of apoptosis/proliferation. Liver cell hypertrophy has previously been described as a mechanism to compensate cell proliferation defects in vivo (Minamishima and Nakayama, 2002). However, the decreased survival of G3mTERC À/À HBsAg þ mice indicated that cellular hypertrophy could not rescue the decreased mouse survival. Our data suggest that impaired liver homeostasis reduced survival of G3mTERC À/À HBsAg þ mice. However, the mice did nor develop any obvious clinical signs of liver failure, like ascitis or bleeding. Thus, we cannot completely exclude the possibility that hepatic HBsAg-transgene expression had some effect on other organs than the liver in aging mTERC À/À mice leading to a reduced survival.
In microarray experiments we showed that telomere shortening induces a set of gene expression changes in liver exposed to chronic organ damage. Interestingly, these genes included a group of genes that regulate mitosis progression. The dysregualtion of such genes has been found during human aging (Ly et al., 2000) . In addition, disturbed mitosis progression has been linked to impaired liver regeneration in mTERC À/À mice in response to partial hepatectomy . Our study shows that re-activation of telomerase by mTERC-gene delivery reverted some of the gene expression changes induced by telomere shortening. These data are in accordance with previous observation that telomerase-gene-delivery rescued defects in liver regeneration in mTERC À/À mice . Together, our current study indicates that telomere stabilization could improve survival in the setting of chronic liver damage despite tumor suppression by shortened telomeres. These data support the idea to develop strategies to target telomeres and the senescence pathway for future therapies in regenerative medicine.
Material and methods

Mice
All mice were maintained under 12 h day/night rhythm in IVC racks under standard diet. The HBsAg transgenic mouse (C57BL/6J-Tg(Alb1HBV)44Bri/J) was purchased from 'The Jackson Laboratory' and mated with heterozygous mTERC 
À/À and G3mTERC À/À mice. In addition, cohorts of mice of these genotypes were killed at 5, 10 and 15 months of age. In these cohorts, the liver weight and total body weight was measured and the relative body weight was calculated. The size and number of macroscopically visible nodules on the liver surface was measured. These nodules and additional sagital sections were prepared from the central part of the median liver lobe for analysis of liver histology.
Histological analysis
For histological analysis, liver samples were fixed in phosphate-buffered 4% formalin (pH 7.3) and embedded in paraffin. In total, 3 mm sections were stained routinely with haematoxylin and eosin. The histopathological evaluation was carried out for foci, hepatocellular adenoma, and carcinoma using a light microscope.
Immunohistochemistry
For immunohistochemical studies, liver tissue was snap frozen and 7 mm sections were prepared. After over night air drying, they were fixated in 4% PFA in cacodylate buffer, dehydrated and stored at À201C until further use.
The following antibodies were used: Mouse anti-PCNA-Ab-1 (Oncogene Science), Mouse anti-human HBsAg (Dako) primary antibodies and cy3-conjugated anti-Mouse IgG secondary antibody (Sigma). The slides were thawed, washed three times in 1 Â PBS and then heat treated in 10 mM citric acid-sodium phosphate buffer for 15 min at 951C. After cooling down to room temperature the slides were incubated for 1 h with primary antibody, then washed three times in 1 Â PBS followed by incubation with the secondary antibody for 45 min at RT. The slides were washed three times with 1 Â PBS and mounted with fluorescence mounting medium containing DAPI. Slides from the following samples were analysed under the microscope at Â 400 magnification: PCNA: 10 months old male mTERC
TUNEL staining
In Situ Cell Death Detection Kit (#1684795, Roche) and manufacturer's protocol was used for TUNEL assay. In brief, 7 mm frozen liver sections were thawed, washed in 1 Â PBS and incubated for 30 min in proteinase K-solution (15 mg/ml). After washing in 1 Â PBS, sections were permeabilized with ice cold 0.1% TritonX-100, 0.1% sodium citrate for 5 min. After two washes with 1 Â PBS sections were incubated with TUNELmix for 1.5 h at 371C. Then the slides were washed three times with 1 Â PBS, air-dried and mounted with fluorescence mounting medium containing DAPI. For analysis TUNEL positive cells in samples from 10 months old male mTERC þ / þ HBsAg þ mice (n ¼ 11) and G3mTERC À/À HBsAg þ mice (n ¼ 7) were counted per lowpower field.
DNA ploidy measurement with Feulgen staining
Paraffin embedded sections of liver samples (of one 15 months old male mTERC
HBsAg þ mice, two G3mTERC À/À HBsAg þ mice and one G3mTERC À/À HBsAg þ mouse) were deparaffinized in xylol and rehydrated in ethanol (abs., 90, and 70% ethanol) for 2 min each. After 1 h fixation in 4% buffered formalin and 2 min washing in 1 Â PBS, sections were incubated for 50 min in 5% HCl to hydrolyse the purin bases of the DNA. After washing in 1 Â PBS, sections were stained with Schiff's reagent for 20 min. Additional washing in 0.5% potassiumdisulfide in 0.5 N HCl was followed by dehydration in ethanol (70, 90%, and abs. ethanol) for 2 min each. After short incubation in xylol the slides were mounted with Entellan. Analysis was carried out with Ahrend's program on digital pictures. For each sample 300 nuclei of hepatocytes were measured and DNA content was automatically calculated on the basis of 30 reference cells (lymphocytes) of the same sample.
Nuclear b-catenin staining
The size of the cells was measured by computer-based analysis (analySISDoku) on b-catenin-positive hepatocyte cell walls. Slides were thawed, washed in 1 Â PBS and endogenous peroxidase activity was blocked by 30 min incubation in 0.3% H 2 O 2 in methanol. After washing the slides once in 1 Â PBS, the sections were permeabilized in Tris-EDTA pH 9.0 at 951C for 20 min. After cooling down the slides to RT, they were washed and incubated with 1% BSA for 15 min. Then the samples were incubated for 2 h with FITC-labeled Anti-bCatenin antibody (BD Bioscience). After the final wash, slides were mounted with fluorescence mounting medium with DAPI. Cell size was measured for mTERC þ / þ HBsAg À mice (n ¼ 3), mTERC 
Adenovirus preparation & CCl 4 injection
AdmTERC and AdGFP adenovirus was produced in 293 cells, purified on CsCl gradients and dialysed. In total, 6-8-week-old mTERC þ / þ or late generation mTERC À/À mice were infected with 10 12 virus particles by tailvein injections. At 2 days after viral application, CCl 4 treatment was started (i.p. injections of 10 ml of 10% CCl 4 in mineral oil per gram of body weight) three times a week for 2 weeks. At 3 days after the last injection liver biopsies were taken.
RNA extraction
The total RNA was extracted according to the manufacturer's protocol (RNA Cleant, Hybaid). The RNA extracted from liver samples of mTERC þ / þ AdGFP , late generation mTERC À/À AdGFP and late generation mTERC À/À AdmTERC mice was used for high-density oligonucleotide microarray analysis.
High-density oligonucleotide microarray hybridization and analysis
Quality and integrity of the total RNA were checked by running all the samples on an Agilent Technologies 2100 Bioanalyzer (Agilent Technologies). The expression analysis was carried out according to standard protocols of the manufacturer (Affymetrix GeneChip Expression Analysis Manual, Affymetrix).
